Pharmaceutical Preparations

"Pharmaceutical Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.

Descriptor ID	D004364
MeSH Number(s)	D26
Concept/Terms	Pharmaceutical Preparations Pharmaceutical Preparations Pharmaceutic Preparations Preparations, Pharmaceutic Preparations, Pharmaceutical Drugs Pharmaceutical Products Products, Pharmaceutical

Below are MeSH descriptors whose meaning is more general than "Pharmaceutical Preparations".

Chemicals and Drugs [D]
Pharmaceutical Preparations [D26]

Below are MeSH descriptors whose meaning is related to "Pharmaceutical Preparations".

Below are MeSH descriptors whose meaning is more specific than "Pharmaceutical Preparations".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pharmaceutical Preparations" by people in this website by year, and whether "Pharmaceutical Preparations" was a major or minor topic of these publications.

Bar chart showing 91 publications over 27 distinct years, with a maximum of 16 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1998	1	1	2
1999	2	0	2
2002	1	0	1
2003	0	2	2
2004	1	0	1
2005	3	3	6
2006	1	0	1
2007	4	3	7
2008	1	1	2
2009	3	2	5
2010	2	1	3
2011	3	1	4
2012	2	1	3
2013	2	2	4
2014	1	0	1
2015	2	0	2
2016	1	1	2
2017	2	1	3
2018	2	2	4
2019	0	1	1
2020	2	1	3
2021	15	1	16
2022	0	7	7
2023	0	5	5
2024	0	2	2
2025	0	1	1

Below are the most recent publications written about "Pharmaceutical Preparations" by people in Profiles.

O'Mahony ET, Arian CM, Aryeh KS, Wang K, Thummel KE, Kelly EJ. Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy. Pharmacol Ther. 2025 Sep; 273:108879.

View in: PubMed
Arian C, O'Mahony E, MacDonald JW, Bammler TK, Donowitz M, Kelly EJ, Thummel KE. Human enteroid monolayers: A novel, functionally stable model for investigating oral drug disposition. Drug Metab Dispos. 2025 Jan; 53(1):100002.

View in: PubMed
Zhang LH, Li JN, Li YH, Min XZ, Kong DY, Han Y, Jiang C, Xiao H, Liang B, Zhang ZF. Tracing residual patterns and microbial communities of pharmaceuticals and personal care products from 17 urban landfills leachate in China. J Hazard Mater. 2024 09 15; 477:135295.

View in: PubMed
Metkar M, Pepin CS, Moore MJ. Tailor made: the art of therapeutic mRNA design. Nat Rev Drug Discov. 2024 01; 23(1):67-83.

View in: PubMed
Caine SB, Plant S, Furbish K, Yerton M, Smaragdi E, Niclou B, Lorusso JM, Chang JY, Bitter C, Basu A, Miller S, Huang CY, Komson R, Liu D, Behar S, Thomsen M. Sprague Dawley rats from different vendors vary in the modulation of prepulse inhibition of startle (PPI) by dopamine, acetylcholine, and glutamate drugs. Psychopharmacology (Berl). 2023 Sep; 240(9):2005-2012.

View in: PubMed
Kempfle JS, Jung DH. Experimental drugs for the prevention or treatment of sensorineural hearing loss. Expert Opin Investig Drugs. 2023 Jul-Dec; 32(7):643-654.

View in: PubMed
Karasz A, Merchant K, Arnsten J, Feinberg J, Kim AY, Lum PJ, McKee MD, Mehta SH, Meissner P, Norton BL, Page K, Pericot-Valverde I, Singh R, Stein E, Taylor LE, Tsui JI, Wagner K, Litwin A. A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences. J Med Internet Res. 2023 06 02; 25:e38176.

View in: PubMed
Laranjeira S, Roberton VH, Phillips JB, Shipley RJ. Perspectives on optimizing local delivery of drugs to peripheral nerves using mathematical models. WIREs Mech Dis. 2023 03; 15(2):e1593.

View in: PubMed
Goyenvalle A, Jimenez-Mallebrera C, van Roon W, Sewing S, Krieg AM, Arechavala-Gomeza V, Andersson P. Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides. Nucleic Acid Ther. 2023 01; 33(1):1-16.

View in: PubMed
Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthritis Cartilage. 2023 04; 31(4):458-466.

View in: PubMed

People

Explore

Similar Concepts

Top Journals